‘Genital Warts (GWs)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Genital Warts in the United States.
Geography Covered • The United States Study Period: 2017–2030
Genital Warts Disease Understanding Genital warts (GWs) are transmitted by having sexual contact with someone who already has them, and may be found on the outside of genitals. Some types, which cause cancer, result in the growth of lesions on a woman’s cervix. It is possible to get genital warts, HPV infection, even if they are not visible. They look like flesh-colored bumps that have a cauliflower-like appearance, and are usually flat, papular, or pedunculated growths on the genital mucosa, occurring in clusters. They can appear on the penis, vulva, vagina, cervix, groin, or thigh within weeks or months after sexual contact with an infected person. Potentially cancer-causing HPV strains are spread by sexual intercourse, anal sex, and oral sex. Moreover, genital Warts is also known as anogenital warts (AGWs) or condylomata acuminata. Genital Warts Epidemiology The Genital Warts (GWs) epidemiology division provides the insights about historical and current patient pool and forecasted trend the United States. The epidemiology data for Genital Warts are studied through all possible division to give a better understanding about the Disease scenario in the United States. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.
Genital Warts Epidemiology Segmentation The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (Total Diagnosed Incidence of GWs, Gender-specific Cases, Age-specific Cases of Genital Warts, HPV type associated with GWs and Anatomical Location of Warts) in the United States from 2017–2030. The report also provides the epidemiology trends observed in the US during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight. According to the report, the total number of diagnosed incident cases of Genital Warts (GWs) in the US was found to be 4,65,000, in the year 2017.
• The report covers detailed overview of Genital Warts explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• The report provides the insight about the historical and forecasted patient pool of Genital Warts in the United States
• The Report assesses the disease risk and burden and highlights the unmet needs of the disease
• The Report helps to recognize the growth opportunities in the United States with respect to the patient population
• The report provides the segmentation of the disease epidemiology by Total Diagnosed Incidence of GWs, Gender-specific Cases, Age-specific Cases of Genital Warts, HPV type associated with GWs and Anatomical Location of Warts in the US
Key strengths • 11 Year Forecast of Genital Warts epidemiology • The US Coverage • Total incident cases of GWs • Incident Cases according to segmentation: Total Diagnosed Incidence of GWs, Gender-specific Cases, Age-specific Cases of Genital Warts, HPV type associated with GWs and Anatomical Location of Warts
• Patient Segmentation • Disease Risk & Burden
• Risk of disease by the segmentation • Factors driving growth in a specific patient population
Our reports have been used by over 10K customers, including:
Kidney Fibrosis - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Kidney Fibrosis - Pipeline Review, H1 2020, provides an overview of the Kidney Fibrosis (Genito Urinary System And Sex Hormones) pipeline landscape. Accumulation of extracellular...
C-C Chemokine Receptor Type 4 - Pipeline Review, H1 2020 Summary C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) - C-C chemokine receptor type 4 is a protein encoded by the CCR4 gene. CCR4 is expressed on Th2 T lymphocytes and is up-regulated by T cell receptor activation. This receptor also...
Aryl Hydrocarbon Receptor - Pipeline Review, H1 2020 Summary Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) - Aryl hydrocarbon receptor is a protein encoded by the AHR gene. It mediates biochemical and toxic effects of halogenated aromatic hydrocarbons. It...
Pigmentation Disorders Treatment Market Research Report by Indication (Hyperpigmentation and Hypopigmentation), by Treatment & Therapies (Chemical Peels, Dermabrasion, Laser Resurfacing, and Melasma), by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Pigmentation Disorders Treatment Market...
Pruritus Global Clinical Trials Review, H1, 2020 Summary This clinical trial report, “Pruritus Global Clinical Trials Review, H1, 2020" provides an overview of Pruritus Clinical trials scenario.This report provides top line data relating to the clinical trials on Pruritus. Report includes...
Peanut Allergy - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Peanut Allergy - Pipeline Review, H1 2020, provides an overview of the Peanut Allergy (Immunology) pipeline landscape. Peanut allergy is common, especially in children. An allergic...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.